Anlon Healthcare Limited has filed its initial disclosure under the SEBI Large Corporate framework, confirming that it does not qualify as a Large Corporate entity for the financial year 2026. The disclosure was submitted to both BSE Limited and the National Stock Exchange of India in compliance with regulatory requirements.

SEBI Framework Compliance

The disclosure was made in accordance with multiple SEBI circulars, including the original circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, subsequent amendments in 2021 and 2022, and the revised framework under SEBI/HO/DDHS/DDHSRACPODI/P/CIR/2023/172 dated October 19, 2023. These regulations establish the criteria for determining Large Corporate status as of March 31, 2026.

Large Corporate Classification Criteria

Under the SEBI framework, companies qualify as Large Corporate entities if they meet three specific conditions as of the last day of the financial year:

The borrowing criteria specifically excludes external commercial borrowings and inter-corporate borrowings between parent and subsidiary companies. For entities with multiple ratings from different agencies, the highest rating is considered for framework applicability.

Company's Non-Qualification Status

Anlon Healthcare Limited has confirmed that it does not fall under the Large Corporate category as per Clause 2.2 of the SEBI framework. The company's Managing Director, Punitkumar Rasadia, signed the disclosure document on April 15, 2026, formally notifying both stock exchanges of this status.

Regulatory Implications

As the company does not meet the Large Corporate criteria, it is exempt from the specific disclosure requirements mandated for Large Corporate entities under the SEBI framework. This exemption applies to all compliance obligations specified in the aforementioned regulations as of March 31, 2026.

The disclosure ensures transparency with regulatory authorities and provides clarity to stakeholders regarding the company's classification under current SEBI guidelines for the financial year 2026.

Anlon Healthcare Limited has successfully concluded its postal ballot process, with shareholders approving all five proposed resolutions through electronic voting. Following this approval, the company has announced April 24, 2026 as the record date for implementing the approved corporate restructuring measures and disclosed detailed alterations to its Memorandum of Association capital clause under Regulation 30.

Record Date and Corporate Actions

The company has fixed Friday, April 24, 2026 as the record date for implementing two major corporate actions approved through the postal ballot process. This announcement was made on April 09, 2026, pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Newspaper Publication Disclosure

Anlon Healthcare Limited has fulfilled its regulatory obligations by publishing newspaper advertisements about the record date determination. The company submitted formal disclosure to BSE Limited and National Stock Exchange on April 10, 2026, pursuant to Regulation 30 read with Regulation 47 of SEBI (LODR) Regulations, 2015.

MOA Capital Clause Alterations

Anlon Healthcare Limited has disclosed comprehensive details of alterations in the capital clause of its Memorandum of Association under Regulation 30. The company submitted formal disclosures to BSE Limited and National Stock Exchange on April 09, 2026, detailing two specific alterations following the postal ballot approvals.

Sub-Division Related Changes

The first alteration relates to the sub-division of equity shares, transforming the authorized share capital structure while maintaining the same monetary value.

Authorized Capital Increase

The second alteration involves doubling the authorized share capital to accommodate future growth and the bonus share issuance.

Postal Ballot Results Overview

The postal ballot was conducted exclusively through remote e-voting, with the voting period spanning from March 10, 2026, at 09:00 AM IST to April 08, 2026, at 05:00 PM IST. All five resolutions received overwhelming support from shareholders across different categories.

Regulatory Compliance and Implementation

The disclosure was made in compliance with Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Managing Director Punitkumar Rasadia signed the formal communication to both stock exchanges, confirming the completion of all regulatory requirements for the MOA alterations.

With the record date fixed for April 24, 2026, eligible shareholders will be entitled to receive benefits of both the stock split and bonus share issuance following the implementation of the altered capital clause provisions. The newspaper publications ensure wider dissemination of this important information to all stakeholders.